Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Powis

Showing results (211-220 of 261) with videos related to

Pageof 27
Sort By:
Anticancer Research|March 12, 1998
Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential antitumor agentsL Engman, I Cotgreave, M Angulo, et al.
Bioorganic & Medicinal Chemistry|May 20, 2000
3Beta-hydroxy-6-aza-cholestane and related analogues as phosphatidylinositol specific phospholipase C (PI-PLC) inhibitors with antitumor activityW Xie, H Peng, L H Zalkow, et al.
Toxicology Letters|January 1, 1991
Platelet-derived growth factor blocks the increase in intracellular free Ca2+ caused by calcium ionophores and a volatile anesthetic agent in Swiss 3T3 fibroblasts without altering toxicityR A Olsen, M J Seewald, D C Melder, et al.
Oncology Research|January 1, 1994
The thioredoxin/thioredoxin reductase redox system and control of cell growthG Powis, J E Oblong, P Y Gasdaska, et al.
Cancer Treatment Reports|November 1, 1981
Phase I and pharmacokinetic studies of DONJ S Kovach, R T Eagan, G Powis, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1987
Cryopreservation of rat and dog hepatocytes for studies of xenobiotic metabolism and activationG Powis, K S Santone, D C Melder, et al.
Biochemistry|December 31, 1997
Human thioredoxin homodimers: regulation by pH, role of aspartate 60, and crystal structure of the aspartate 60 --> asparagine mutantJ F Andersen, D A Sanders, J R Gasdaska, et al.
Cancer Research|August 1, 1990
Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analoguesM J Seewald, R A Olsen, I Sehgal, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
European School of Oncology Task Force Report. New approaches in cancer pharmacology: drug design and development (Part 2)P Workman, M D'Incalci, W Bursch, et al.
Anti-Cancer Drug Design|August 1, 1994
A multisample assay for inhibitors of phosphatidylinositol phospholipase C: identification of naturally occurring peptide inhibitors with antiproliferative activityS R Hill, R Bonjouklian, G Powis, et al.
Pageof 27

Showing results (211-220 of 261) with videos related to

Sort By:
Pageof 27
Anticancer Research|March 12, 1998
Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential antitumor agentsL Engman, I Cotgreave, M Angulo, et al.
Bioorganic & Medicinal Chemistry|May 20, 2000
3Beta-hydroxy-6-aza-cholestane and related analogues as phosphatidylinositol specific phospholipase C (PI-PLC) inhibitors with antitumor activityW Xie, H Peng, L H Zalkow, et al.
Toxicology Letters|January 1, 1991
Platelet-derived growth factor blocks the increase in intracellular free Ca2+ caused by calcium ionophores and a volatile anesthetic agent in Swiss 3T3 fibroblasts without altering toxicityR A Olsen, M J Seewald, D C Melder, et al.
Oncology Research|January 1, 1994
The thioredoxin/thioredoxin reductase redox system and control of cell growthG Powis, J E Oblong, P Y Gasdaska, et al.
Cancer Treatment Reports|November 1, 1981
Phase I and pharmacokinetic studies of DONJ S Kovach, R T Eagan, G Powis, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1987
Cryopreservation of rat and dog hepatocytes for studies of xenobiotic metabolism and activationG Powis, K S Santone, D C Melder, et al.
Biochemistry|December 31, 1997
Human thioredoxin homodimers: regulation by pH, role of aspartate 60, and crystal structure of the aspartate 60 --> asparagine mutantJ F Andersen, D A Sanders, J R Gasdaska, et al.
Cancer Research|August 1, 1990
Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analoguesM J Seewald, R A Olsen, I Sehgal, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
European School of Oncology Task Force Report. New approaches in cancer pharmacology: drug design and development (Part 2)P Workman, M D'Incalci, W Bursch, et al.
Anti-Cancer Drug Design|August 1, 1994
A multisample assay for inhibitors of phosphatidylinositol phospholipase C: identification of naturally occurring peptide inhibitors with antiproliferative activityS R Hill, R Bonjouklian, G Powis, et al.
Pageof 27